Journal article
New perspectives on target intraocular pressure.
-
Clement CI
Glaucoma Unit, Sydney Eye Hospital, Sydney, Australia; The University of Sydney, Sydney, Australia. Electronic address: colinandkylie@me.com.
-
Bhartiya S
Fortis Memorial Research Institute Sector 44, Gurgaon, Haryana, India.
-
Shaarawy T
Ophthalmology Service, Department of Clinical Neurosciences, University of Geneva, Switzerland.
Published in:
- Survey of ophthalmology. - 2014
English
The evidence in support of intraocular pressure (IOP) lowering to reduce risk of glaucoma onset or progression is strong, although the amount and quality of IOP reduction is less well defined. The concept of a target IOP includes a percentage reduction, calculated IOP, or a predetermined IOP figure or range. Yet none of these strategies have been validated. In addition, our understanding of the way IOP influences glaucoma risk is continuously evolving. Examples of this include the data on IOP fluctuation and lamina cribrosa and cerebrospinal fluid pressure differentials. That these variables are not included in target IOP calculation potentially undermines its accuracy and usefulness. We summarize the evidence for target IOP, new developments in our understanding of IOP and glaucoma pathogenesis, as well as emerging strategies for setting targets and assessing response to treatment.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/118334
Statistics
Document views: 50
File downloads: